Westway Health

Westway Health is an Irish biotechnology company focused on developing innovative, non-antibiotic antimicrobial solutions to address the global challenge of antibiotic resistance. Spun out from the National University of Ireland Galway, the company utilizes a proprietary dual-component technology that generates reactive oxygen species to effectively eliminate a broad spectrum of pathogens, including multi-drug resistant strains like MRSA. Its lead product, Bovimast, targets bovine mastitis in dairy cattle and is notable for requiring no milk withdrawal period, offering significant economic benefits to farmers. Beyond animal health, Westway Health is advancing research into human healthcare applications, specifically targeting chronic wound infections and respiratory tract diseases.